Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Scientists develop new drugs to fight colon and breast cancer more effectively

04.06.2007
The doctoral thesis 'Potencial terapéutico de nuevos fármacos antitumorales. Estudio sobre líneas celulares epiteliales' (Therapeutic Potential of New Antitumor Drugs.

A Study on Epithelial Cell Lines) has allowed for the development of six new drugs to fight colon and breast cancer more effectively than other currently used drugs. The study was conducted at the Department of Human Anatomy and Embryology at the University of Granada (Universidad de Granada [http://www.ugr.es]) by Octavio Caba Pérez, member of the research group "Avances en Biomedicina" (Progress in Biomedicine), under the direction of professors Antonia Aránega, Juan Antonio Marchal and Fernando Rodríguez.

The importance of this study, in which researchers from the Department of Pharmaceutical and Organic Chemistry have also collaborated, is that it enabled the identification of a total of six antitumor compounds similar to 5-fluorouracil (5-FU), one of the most widely-used drugs nowadays to fight colon and breast cancer. These compounds are more effective against malignant cells (those which are cancerous) and less toxic against benign cells (those which are unnecessarily destroyed or harmed with treatments such as chemotherapy).

As Caba Pérez points out, the current method used to fight tumors “produces several 'collateral damages'. A drug can be very effective against breast cancer, but it can also affect the rest of the benign epithelial tissue. As everybody knows, current treatments for cancer destroy a large number of unaffected cells in addition to affected cells,” says Caba Pérez.

... more about:
»Caba »Perez »colon

In this study researchers analyzed more than 150 drugs aimed at reducing the toxicity of the 5-FU against the benign cells, thus avoiding the reproduction of new carcinomas or other side effects. “We discarded compounds until we finally found six which have shown to be better than currently used drugs,” says Caba Pérez.

Research on cell lines

So far, the study has been conducted on cell lines, and not on patients, using a new technique called “Microarrays” or “DNA Chips”, which enables the identification of the effects produced by drugs on each gene — the lowest and most specific level that Medicine can deal with.

“Our research,” says Caba Pérez, “has been conducted with absolute precision with the aim of obtaining the lowest possible concentration of drug producing the most significant effect on cancerous cells”. Therefore, this study has shown the importance of the presence of some toxic compounds like chlorine, flourine or uracil in drugs. This presence is one of the variables used to develop new antitumor drugs.

Part of the results of this study (which has been possible thanks to cooperation between the UGR [http://www.ugr.es] and the company VILPOMAS) have been published in the January 1 issue of the international journal "Tetrahedron". The remainder of the results will be published in various international journals on Biomedicine.

Antonio Marín Ruiz | alfa
Further information:
http://prensa.ugr.es/prensa/research/index.php

Further reports about: Caba Perez colon

More articles from Life Sciences:

nachricht A study demonstrates that p38 protein regulates the formation of new blood vessels
17.07.2019 | Institute for Research in Biomedicine (IRB Barcelona)

nachricht For bacteria, the neighbors co-determine which cell dies first: The physiology of survival
17.07.2019 | Technische Universität München

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Megakaryocytes act as „bouncers“ restraining cell migration in the bone marrow

Scientists at the University Würzburg and University Hospital of Würzburg found that megakaryocytes act as “bouncers” and thus modulate bone marrow niche properties and cell migration dynamics. The study was published in July in the Journal “Haematologica”.

Hematopoiesis is the process of forming blood cells, which occurs predominantly in the bone marrow. The bone marrow produces all types of blood cells: red...

Im Focus: Artificial neural network resolves puzzles from condensed matter physics: Which is the perfect quantum theory?

For some phenomena in quantum many-body physics several competing theories exist. But which of them describes a quantum phenomenon best? A team of researchers from the Technical University of Munich (TUM) and Harvard University in the United States has now successfully deployed artificial neural networks for image analysis of quantum systems.

Is that a dog or a cat? Such a classification is a prime example of machine learning: artificial neural networks can be trained to analyze images by looking...

Im Focus: Extremely hard yet metallically conductive: Bayreuth researchers develop novel material with high-tech prospects

An international research group led by scientists from the University of Bayreuth has produced a previously unknown material: Rhenium nitride pernitride. Thanks to combining properties that were previously considered incompatible, it looks set to become highly attractive for technological applications. Indeed, it is a super-hard metallic conductor that can withstand extremely high pressures like a diamond. A process now developed in Bayreuth opens up the possibility of producing rhenium nitride pernitride and other technologically interesting materials in sufficiently large quantity for their properties characterisation. The new findings are presented in "Nature Communications".

The possibility of finding a compound that was metallically conductive, super-hard, and ultra-incompressible was long considered unlikely in science. It was...

Im Focus: Modelling leads to the optimum size for platinum fuel cell catalysts: Activity of fuel cell catalysts doubled

An interdisciplinary research team at the Technical University of Munich (TUM) has built platinum nanoparticles for catalysis in fuel cells: The new size-optimized catalysts are twice as good as the best process commercially available today.

Fuel cells may well replace batteries as the power source for electric cars. They consume hydrogen, a gas which could be produced for example using surplus...

Im Focus: The secret of mushroom colors

Mushrooms: Darker fruiting bodies in cold climates

The fly agaric with its red hat is perhaps the most evocative of the diverse and variously colored mushroom species. Hitherto, the purpose of these colors was...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

2nd International Conference on UV LED Technologies & Applications – ICULTA 2020 | Call for Abstracts

24.06.2019 | Event News

SEMANTiCS 2019 brings together industry leaders and data scientists in Karlsruhe

29.04.2019 | Event News

Revered mathematicians and computer scientists converge with 200 young researchers in Heidelberg!

17.04.2019 | Event News

 
Latest News

Tracking down climate change with radar eyes

17.07.2019 | Earth Sciences

Researchers build transistor-like gate for quantum information processing -- with qudits

17.07.2019 | Information Technology

A new material for the battery of the future, made in UCLouvain

17.07.2019 | Materials Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>